We found that downregulation of FOXC2 decreased the tumor volume, tumor weight, and Ki-67 positivity of SGC7901/ADR cells receiving ADR treatment (Figures 3J, K and Supplementary Figure 2J). This evidence concerns the gene MKI67 and neoplasm.